• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.35% Nasdaq Up 1.43%

    Oncothyreon Inc (ONTY)

    -NasdaqGS
    1.88 Up 0.08(4.44%) 10:44AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:1.80
    Open:1.84
    Bid:1.88 x 5500
    Ask:1.89 x 7300
    1y Target Est:3.67
    Beta:1.54
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:1.84 - 1.92
    52wk Range:1.52 - 4.08
    Volume:276,681
    Avg Vol (3m):824,394
    Market Cap:172.12M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ONTY

    Comparison

    Symbol% ChgMkt Cap
    ONTYUp 4.44%172.12M
    GSKUp 2.36%103.45B
    RHHBYUp 2.02%249.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:08-May-95

    Analysts

    Annual EPS Est (Dec-14) :-0.40
    Quarterly EPS Est (Dec-14) :-0.09
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback